UK Biopharmaceutical Excipients Market Size & Outlook
UK biopharmaceutical excipients market, 2018-2030 (US$M)
Related Markets
UK biopharmaceutical excipients market highlights
- The UK biopharmaceutical excipients market generated a revenue of USD 118.8 million in 2023 and is expected to reach USD 173.9 million by 2030.
- The UK market is expected to grow at a CAGR of 5.6% from 2024 to 2030.
- In terms of segment, carbohydrates was the largest revenue generating product in 2023.
- Polyols is the most lucrative product segment registering the fastest growth during the forecast period.
Biopharmaceutical excipients market data book summary
| Market revenue in 2023 | USD 118.8 million |
| Market revenue in 2030 | USD 173.9 million |
| Growth rate | 5.6% (CAGR from 2023 to 2030) |
| Largest segment | Carbohydrates |
| Fastest growing segment | Polyols |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Specialty Excipients/Others, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates |
| Key market players worldwide | Merck KGaA, Basf SE, Associated British Foods PLC, IMCD NV, Clariant AG, Evonik Industries AG, Colorcon, Sigachi, Spectrum Chemical Manufacturingrp, Roquette America, DFE Pharma, J. Rettenmaier & Söhne |
Other key industry trends
- In terms of revenue, UK accounted for 4.6% of the global biopharmaceutical excipients market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany biopharmaceutical excipients market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 157.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Excipients Market Scope
Biopharmaceutical Excipients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK biopharmaceutical excipients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 35.77% in 2023. Horizon Databook has segmented the UK biopharmaceutical excipients market based on specialty excipients/others, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2018 to 2030.
The UK biopharmaceutical market has potential strengths and opportunities favoring the growing use of excipients. Top three segments that account for the maximum share in the UK biopharmaceutical market include small molecules, therapeutic proteins, and antibodies.
For instance, “Invest in Great Britain and Northern Ireland” is one such initiative undertaken by UK government. Through this initiative the government offers guidelines to overseas businesses, offering them advice and support to set up businesses in the UK.
Reasons to subscribe to UK biopharmaceutical excipients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK biopharmaceutical excipients market databook
-
Our clientele includes a mix of biopharmaceutical excipients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK biopharmaceutical excipients market , including forecasts for subscribers. This country databook contains high-level insights into UK biopharmaceutical excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK biopharmaceutical excipients market size, by product, 2018-2030 (US$M)
UK Biopharmaceutical Excipients Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
